Patent Assignment
Reel/Frame 061808/0420
Change of Name
Recorded: 2022-10-31
Pages: 4
Assignor
UPJOHN US 1 LLC
Executed: 2022-01-01
Assignee
VIATRIS SPECIALTY LLC.
3711 COLLINS FERRY ROAD, MORGANTOWN, WEST VIRGINIA, 26505
Covered Properties
(29)
Liquid Pharmaceutical Compositions
Prodrugs of Amino Acids with Affinity for the ALPHA2DELTA-Protein
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoicacid Calcium Salt (2:1)
Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
Process for Forming Amorphous Atorvastatin
Process for Annealing Amorphous Atorvastatin
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Magnesium
Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
Preparation of Pregabalin and Related Compounds
Process for Preparing Chiral Compounds
Preparation of Pregabalin and Related Compounds
Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Alpha-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
Process for Forming Amorphous Atorvastatin
Novel Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylmino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)
Preparation of Pregabalin and Related Compounds
NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)
Process for Preparing Chiral Compounds
Process for Forming Amorphous Atorvastatin
Solid Pharmaceutical Compositions Containing Pregabalin
Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)
Solid Pharmaceutical Compositions Containing Pregabalin
Process For Annealing Amorphous Atorvastatin
Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)
Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)
Solid Pharmaceutical Compositions Containing Pregabalin
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 11, 2003
From: KULKARNI, NEEMA M.; SCHNEIDER, MICHAEL; SILBERING, STEVEN B.; MEYER-WONNAY, HANS
To: WARNER-LAMBERT COMPANY LLC
Reel/Frame 014189/0695 →
Change of Address
Jul 5, 2016
From: WARNER-LAMBERT COMPANY LLC
To: WARNER-LAMBERT COMPANY LLC
Reel/Frame 039254/0210 →
Assignment of Assignor's Interest
Nov 6, 2020
From: PFIZER INC.
To: UPJOHN US 1 LLC
Reel/Frame 054293/0154 →
Assignment of Assignor's Interest
Nov 6, 2020
From: WARNER-LAMBERT COMPANY LLC
To: UPJOHN US 1 LLC
Reel/Frame 054293/0956 →